BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28423383)

  • 1. Remarkable Advances in the Management of Mycosis Fungoides and the Sezary Syndrome.
    Hoppe RT
    Oncol Res Treat; 2017; 40(5):242-243. PubMed ID: 28423383
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the Committee on Therapy for Mycosis Fungoides and Sézary Syndrome.
    Minna JD; Roenigk HH; Glatstein E
    Cancer Treat Rep; 1979 Apr; 63(4):729-36. PubMed ID: 109209
    [No Abstract]   [Full Text] [Related]  

  • 3. New options in diagnosis and management of mycosis fungoides and Sézary syndrome.
    Enke CA
    Oncology (Williston Park); 2010 May; 24(6):507-8. PubMed ID: 20568591
    [No Abstract]   [Full Text] [Related]  

  • 4. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome.
    Jothishankar B; Almazan T; Kim Y; Liauw S; Smith S; Kline J; Abdulla F
    Br J Haematol; 2019 Jul; 186(2):377-379. PubMed ID: 30937886
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycosis fungoides and the Sézary syndrome.
    Gisselbrecht C; Dubertret L
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
    [No Abstract]   [Full Text] [Related]  

  • 6. [Total skin electron therapy of mycosis fungoides and the Sézary syndrome].
    Herbst M; Müller R
    Hautarzt; 1984 Jan; 35(1):16-21. PubMed ID: 6423569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
    Bunn PA; Fischmann AB; Schechter GP; Kumar PP; Ihde DC; Cohen MH; Fossieck BE; Gazdar AF; Matthews MJ; Eddy JL; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):713-7. PubMed ID: 109208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of mycosis fungoides/Sezary syndrome: the University of California, San Francisco (UCSF) approach.
    Zackheim HS
    Int J Dermatol; 2003 Jan; 42(1):53-6. PubMed ID: 12581145
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome.
    Elsayad K; Stadler R; Steinbrink K; Eich HT
    J Dtsch Dermatol Ges; 2020 Mar; 18(3):193-197. PubMed ID: 32077638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.
    Molin S; Ruzicka T
    Br J Dermatol; 2009 Dec; 161(6):1420-2. PubMed ID: 19785592
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
    Hughes CF; Newland K; McCormack C; Lade S; Prince HM
    Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS).
    Atilla E; Atilla PA; Bozdag SC; Yuksel MK; Toprak SK; Topcuoglu P; Akay BN; Sanli H; Gurman G; Ozcan M
    Int J Hematol; 2017 Sep; 106(3):426-430. PubMed ID: 28466385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell lymphoma.
    Lansigan F; Choi J; Foss FM
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we treat mycosis fungoides and Sézary syndrome.
    Khan N; Noor SJ; Horwitz S
    Clin Adv Hematol Oncol; 2021 Sep; 19(9):573-581. PubMed ID: 34495021
    [No Abstract]   [Full Text] [Related]  

  • 17. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
    Furue M; Kadono T
    J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B
    Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
    [No Abstract]   [Full Text] [Related]  

  • 19. Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome.
    Baron MK; Osborn JD; Tao R; Lee CJ
    Leuk Lymphoma; 2020 Jan; 61(1):231-233. PubMed ID: 31452419
    [No Abstract]   [Full Text] [Related]  

  • 20. A new nail in the CTCL coffin.
    Lessin SR
    J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.